Cladribine is part of a wider trend in the NHS toward embracing time-saving innovations. Similar treatments, such as the ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing take at home tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

“Broadening access to cladribine means thousands more patients will benefit from managing their treatment at home rather than regularly attending hospital appointments – as well giving women with MS ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

Merck KGaA’s Mavenclad (cladribine) tablets have been recommended by the National Institute for Health and Care Excellence ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...

The Scottish Medicines Consortium is reviewing cladribine for broader use in relapsing forms of the condition.

The move will also “significantly free up clinical time” by reducing the need for hospital appointments, officials said. | ITV National News ...

Broadening access to cladribine should help more patients avoid hospital and free up clinic time.

Cladribine is rapidly absorbed with maximum concentration reached 30–50 min after oral administration and 0–20% bound to plasma protein. The half-life varies from 5.6 to 7.6 h and 18.4 to 19.7 ...

An American woman whose dad had to be taken to hospital while on holiday in Spain was shocked when the medical bill came to £157 ($200). Anna Ochoa, 39, has been living in Spain for five months and ...